(AVUV) Avantis U.S. Small Cap Value - Overview
Etf: Equity, Derivatives, Small-Cap, U.S
Dividends
| Dividend Yield | 1.69% |
| Yield on Cost 5y | 2.64% |
| Yield CAGR 5y | 12.12% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 22.7% |
| Relative Tail Risk | -9.86% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.68 |
| Alpha | 3.12 |
| Character TTM | |
|---|---|
| Beta | 1.016 |
| Beta Downside | 1.078 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.79% |
| CAGR/Max DD | 0.49 |
Description: AVUV Avantis U.S. Small Cap Value December 19, 2025
Avantis® U.S. Small-Cap Value ETF (AVUV) targets a broad array of U.S. small-cap equities, allocating at least 80 % of its net assets to companies with market capitalizations typically under $2 billion. The fund may also employ derivatives-including futures, currency forwards, and swaps-to manage exposure or enhance returns, but its core mandate remains a value-biased selection of small-cap stocks across multiple sectors.
Key quantitative insights (as of the most recent filing): the fund’s weighted-average market cap is roughly $1.3 billion, its expense ratio stands at 0.25 %, and the top sector allocations are financials (≈25 %), industrials (≈22 %), and consumer discretionary (≈15 %). Small-cap value historically outperforms the broader market in periods of rising earnings and low inflation, with a 5-year annualized excess return of about 2.8 % versus the Russell 2000 Value Index. Current macro drivers-such as the Federal Reserve’s policy stance on interest rates and the pace of U.S. GDP growth-are likely to influence earnings momentum for these firms, especially in rate-sensitive financials.
For a deeper dive into how AVUV’s valuation metrics compare to peers, you might explore ValueRay’s analytical tools, which can help surface hidden risk-adjusted opportunities.
What is the price of AVUV shares?
Over the past week, the price has changed by +5.42%, over one month by +8.52%, over three months by +19.27% and over the past year by +19.02%.
Is AVUV a buy, sell or hold?
What are the forecasts/targets for the AVUV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 132 | 14.6% |
AVUV Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 22.18b USD (22.18b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 22.18b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 22.18b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.66% (E(22.18b)/V(22.18b) * Re(9.66%) + (debt-free company))
Discount Rate = 9.66% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)